Pacira BioSciences Inc. (PCRX)
NASDAQ · Healthcare
Pacira BioSciences Inc. EBITDA 2009–2025
Pacira BioSciences Inc. annual/quarterly ebitda history and growth rate from 2009 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Pacira BioSciences Inc. ebitda for the quarter ending March 31, 2026 was 28.2 M, a 21.91% increase year-over-year.
- Pacira BioSciences Inc. ebitda for the twelve months ending March 31, 2026 was 99.5 M, a 12.72% increase year-over-year.
- Pacira BioSciences Inc. annual ebitda for 2025 was 110.2 M, a 1935.72% increase from 2024.
- Pacira BioSciences Inc. annual ebitda for 2024 was 5.4 M, a 96.68% decrease from 2023.
- Pacira BioSciences Inc. annual ebitda for 2023 was 163.2 M, a 7.74% increase from 2022.
- Pacira BioSciences Inc. annual ebitda for 2022 was 151.5 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pacira BioSciences Inc. EBITDA — FAQ
Pacira BioSciences Inc. (PCRX) ebitda over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCRX's ebitda history?
The chart and table above show Pacira BioSciences Inc.'s ebitda by year and by quarter, including the growth rate.